| Early treatment for Covid-19 with SARS-CoV-2 neutralizing antibody sotrovimab A Gupta, Y Gonzalez-Rojas, E Juarez, M Crespo Casal, J Moya, DR Falci, ... New England Journal of Medicine 385 (21), 1941-1950, 2021 | 1047 | 2021 |
| The benefits to communities and individuals of screening for active tuberculosis disease: a systematic review [State of the art series. Case finding/screening. Number 2 in the … K Kranzer, H Afnan-Holmes, K Tomlin, JE Golub, AE Shapiro, A Schaap, ... The international journal of tuberculosis and lung disease 17 (4), 432-446, 2013 | 286 | 2013 |
| Effect of sotrovimab on hospitalization or death among high-risk patients with mild to moderate COVID-19: a randomized clinical trial A Gupta, Y Gonzalez-Rojas, E Juarez, MC Casal, J Moya, DR Falci, ... Jama 327 (13), 1236-1246, 2022 | 238 | 2022 |
| Epidemiology of helminth infections and their relationship to clinical malaria in southwest Uganda AE Shapiro, EM Tukahebwa, J Kasten, SE Clarke, P Magnussen, A Olsen, ... Transactions of the Royal Society of Tropical Medicine and Hygiene 99 (1), 18-24, 2005 | 171 | 2005 |
| Community-based targeted case finding for tuberculosis and HIV in household contacts of patients with tuberculosis in South Africa AE Shapiro, E Variava, MH Rakgokong, N Moodley, B Luke, S Salimi, ... American journal of respiratory and critical care medicine 185 (10), 1110-1116, 2012 | 139 | 2012 |
| Community-based antiretroviral therapy versus standard clinic-based services for HIV in South Africa and Uganda (DO ART): a randomised trial RV Barnabas, AA Szpiro, H van Rooyen, S Asiimwe, D Pillay, NC Ware, ... The lancet Global health 8 (10), e1305-e1315, 2020 | 100 | 2020 |
| Effect of subcutaneous casirivimab and imdevimab antibody combination vs placebo on development of symptomatic COVID-19 in early asymptomatic SARS-CoV-2 infection: a randomized … MP O’Brien, E Forleo-Neto, N Sarkar, F Isa, P Hou, KC Chan, BJ Musser, ... Jama 327 (5), 432-441, 2022 | 98 | 2022 |
| Community-based active case-finding interventions for tuberculosis: a systematic review RM Burke, M Nliwasa, HRA Feasey, LH Chaisson, JE Golub, F Naufal, ... The Lancet Public Health 6 (5), e283-e299, 2021 | 95 | 2021 |
| Treatment for HIV‐associated cryptococcal meningitis MW Tenforde, AE Shapiro, B Rouse, JN Jarvis, T Li, I Eshun‐Wilson, ... Cochrane Database of Systematic Reviews, 2018 | 81 | 2018 |
| Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates J Boonyaratanakornkit, C Morishima, S Selke, D Zamora, S McGuffin, ... The Journal of clinical investigation 131 (3), 2021 | 78 | 2021 |
| A systematic review of the number needed to screen to detect a case of active tuberculosis in different risk groups AE Shapiro, R Chakravorty, T Akande, K Lonnroth, JE Golub World Health Organization 86, 2013 | 49 | 2013 |
| An implementation study of oral and blood‐based HIV self‐testing and linkage to care among men in rural and peri‐urban KwaZulu‐Natal, South Africa AE Shapiro, A van Heerden, M Krows, K Sausi, N Sithole, TT Schaafsma, ... Journal of the International AIDS Society 23, e25514, 2020 | 48 | 2020 |
| Isoniazid preventive therapy plus antiretroviral therapy for the prevention of tuberculosis: a systematic review and meta-analysis of individual participant data JM Ross, A Badje, MX Rangaka, AS Walker, AE Shapiro, KK Thomas, ... The Lancet HIV 8 (1), e8-e15, 2021 | 47 | 2021 |
| Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis A Dhana, Y Hamada, AP Kengne, AD Kerkhoff, MX Rangaka, T Kredo, ... The Lancet Infectious Diseases 22 (4), 507-518, 2022 | 44 | 2022 |
| C-reactive protein as a screening test for HIV-associated pulmonary tuberculosis prior to antiretroviral therapy in South Africa AE Shapiro, T Hong, S Govere, H Thulare, MY Moosa, A Dorasamy, ... Aids 32 (13), 1811-1820, 2018 | 39 | 2018 |
| Successful treatment of prolonged, severe coronavirus disease 2019 lower respiratory tract disease in a B cell acute lymphoblastic leukemia patient with an extended course of … ES Ford, W Simmons, EN Karmarkar, LH Yoke, AB Braimah, JJ Orozco, ... Clinical Infectious Diseases 76 (5), 926-929, 2023 | 35 | 2023 |
| Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020. AE Shapiro, RAB Ignacio, BM Whitney, JA Delaney, RM Nance, ... JAIDS Journal of Acquired Immune Deficiency Syndromes, 10.1097, 2022 | 35 | 2022 |
| Diagnosing pulmonary tuberculosis by using sequence-specific purification of urine cell-free DNA A Oreskovic, N Panpradist, D Marangu, MW Ngwane, ZP Magcaba, ... Journal of clinical microbiology 59 (8), 10.1128/jcm. 00074-21, 2021 | 34 | 2021 |
| Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms AE Shapiro, JM Ross, M Yao, I Schiller, M Kohli, N Dendukuri, ... Cochrane Database of Systematic Reviews, 2021 | 28 | 2021 |
| Indoor air pollution from secondhand tobacco smoke, solid fuels, and kerosene in homes with active tuberculosis disease in South Africa JL Elf, O Eke, M Rakgokong, E Variava, Y Baliram, K Motlhaoleng, ... BMC research notes 10, 1-6, 2017 | 27 | 2017 |
Jonathan GolubProfessor, Johns Hopkins UniversityVerified email at jhmi.edu
